ABIOMED, Inc.
Supplier profile
ABIOMED, Inc.
22 Cherry Hill DriveDanvers
Massachusetts 01923
Tel:
978-777-5410
Fax: 978-777-8411
contact: marketing@abiomed.com
website: http://www.abiomed.com
Fax: 978-777-8411
contact: marketing@abiomed.com
website: http://www.abiomed.com
 |
Abiomed(NASDAQ: ABMD) is a global technology leader focused on RECOVERING HEARTS AND SAVING LIVES.The Company's portfolio of heart support and recovery products and services offer healthcare professionals an array of choices across a broad clinical spectrum. From the catheterization lab to the surgical suite, together with interventional cardiologists and surgeons, Abiomed is dedicated to providing the most advanced medical technologies to heart patients, with the ultimate goal of heart recovery and improved quality of life. Abiomed was founded more than two decade ago and is the only company in the world with exclusive labeling on ventricular assist devices for all potentially recoverable heart failure indications. The Company develops, manufactures and markets advanced medical technologies designed to assist or replace the pumping function of the failing heart. Abiomed is the global leader for products in the acute heart failure market and ships more ventricular assist devices (VADs) than any other company in the world. |
|
The Company is focused on expanding its global distribution, fueling innovation and new products to broaden the Company's product portfolio to become the world's circulatory care leader. Key Facts:
Product and Service Offerings:
|
|
Products
| Heart Recovery and Assist | |
 |
Impella The IMPELLA devices are minimally invasive catheter pumps that can support the heart with up to 6.0 liter blood per minute. The pumps can be implanted percutaneously, via a cut-down, or in the OR. |
 |
iPulseIAB The iPulse™ intra-aortic Balloon Catheter is a 40cc. 8F. intra-aortic counterpulsation device that passively unloads the left ventricle, reduces the workload of the heart and enhances cardiac output by approximately 0.8 L/min.1 |
 |
AB5000 The AB5000 Circulatory Support System is driven by a single console that supports bi-ventricular BVS® 5000 blood pumps, AB5000™ ventricles or a combination of the two (transition between the two without reopening the chest). |
 |
BVS 5000 The BVS 5000 was the first extracorporeal, or outside the body, ventricular assist device on the market and is still the most widely used bridge to recovery device with systems located in more than 700 institutions throughout the world. |
| Heart Replacement | |
 |
AbioCor A product of three decades of research, development and testing, the AbioCor is central to ABIOMED's mission to make real the day when heart failure need not mean the end of life or the ability to enjoy life. |
iPulse IAB
| iPulse IAB | |
The iPulse is a multipurpose mechanical circulatroy support system for use in patients suffering from acute cardiovascular failure. It can be used to drive exclusively one of two classes of therapeutic devices: either pneumatically acuated Ventricular Assist Devices (VADs) for total circulatory support, or (i.e., non-simultaneously) an intra-aortic balloon (IAB) catheter for counterpulsation therapy. Abiomed’s iPulse™ intra-aortic Balloon Catheter is a 40cc. 8F. intra-aortic counterpulsation device that passively unloads the left ventricle, reduces the workload of the heart and enhances cardiac output by approximately 0.8 L/min.1 The iPulse™ Catheter can be used on the iPulse™ Console or on other OEM consoles. |
|
 |
Key Features:
|
| Downloads | |
 |
|
BVS 5000
| BVS 5000 | |
Features
|
|
BVS5000 Pump
 BVS5000 Console
 |
Description The BVS 5000 can support one or both sides of the failing heart and can be operated with one of three ABIOMED consoles, the BVS 5000i, BVS 000t and the AB5000 Console. The BVS Blood Pumps use the same cannula as the AB5000 Ventricle allowing for seamless transition of devices without requiring an additional surgical procedure. The BVS 5000 is designed to provide short-term support and recovery to the failing heart. The typical length of support on the BVS 5000 is approximately 7-10 days. |
| ABIOMED BVS 5000 Circulatory Support System Online Demo | |
 |
As part of its ongoing commitment to customer education and support, ABIOMED is pleased to introduce a new online learning program for our products. This web based learning module is designed to create an engaging experience to educate users, and then assess what they have learned. The courses include a set of interactive scenario-based simulations, allowing the clinician to demonstrate understanding of the clinical and functional aspects of ABIOMED's Circulatory Support Systems. Click here to access a free demonstration of the course. |
AbioCor
| AbioCor | |
| Description The AbioCor is the world's first completely self-contained replacement heart. A product of three decades of research, development and testing, the AbioCor is central to ABIOMED's mission to make real the day when heart failure need not mean the end of life or the ability to enjoy life. Designed to fully sustain the body's circulatory system, the AbioCor is intended for end-stage heart failure patients whose other treatment options have been exhausted. |
|
AbioCor Implantable Replacement Heart  |
Indications The AbioCor is indicated for use in severe biventricular end stage heart disease patients who are not cardiac transplant candidates and who:
|
| Downloads | |
Impella 2.5
| Impella 2.5 | |
| Easy to Use & Minimally Invasive The Impella 2.5 is a minimally invasive, catheter-based cardiac assist device designed to:
|
|
 |
The Impella 2.5 can be inserted into the left ventricle in a Cath Lab via a standard guidewire through the femoral artery, into the ascending aorta, across the valve and into the left ventricle. The tip of the catheter contains a “pigtail” that crosses the patient’s heart valve and rests in the left ventricle, generating flows up to 2.5 L/min. Proven Breakthrough Technology The Impella 2.5 has been used to provide partial circulatory support in over 600 patients worldwide. Results from these experiences include:
|
Economic Advantage
|
|
| Downloads | |
AB5000
| AB5000 | |
Features
|
|
  |
Decription The AB5000 Circulatory Support System provides temporary support for one or both sides of the natural heart in circumstances where the heart has failed, giving the patient's heart the opportunity to rest and potentially recover. The AB5000 Ventricle is vacuum assisted technology with clear housing to allow clinicians a view into the device. It use the same cannula as the BVS 5000 Blood Pumps, allowing for seamless transition of devices without requiring an additional surgical procedure. Unlike other ventricular assist systems that can require multiple drivers for a single patient, patients on the AB5000 Ventricle require only a single console – regardless of condition. The AB5000 Console is designed to allow patients to leave their hospital rooms and walk within the hospital and on hospital grounds. Multiple studies have shown that patient ambulation, or walking, greatly assists the recovery process. The ease of use and transport capability of the AB5000 System makes it an important option for both regional and local cardiac centers. Patients can be put on the AB5000 or the BVS 5000 System at their local hospital and then be transported to more advanced cardiac centers if necessary. |
| Downloads | |
Patient Success Stories
| Patient Success Stories | |
 |
In January 2006, Mrs. Rosemary Donaghue recovered her heart after Bi-VAD assistance from the AB5000. Mrs. Donaghue recently had a heart attack and, following surgery, went into cardiogenic shock. She was intubated, on inotropes and an intra-aortic balloon pump, but she needed more support to pump her blood and rest her heart. Her only chance for survival was more potent circulatory support, so Dr. Lou Samuels placed her on biventricular (Bi-VAD) AB5000 circulatory support. Following 11 days of Abiomed Ventricular Assist Device (VAD) support, her heart was able to function on its own. |
 |
Rudranauth Persaud a 44 year old software programmer, had just returned from vacation with his wife and three children when he began to experience chest pain. He was taken to North Shore University Hospital, where it was discovered he was having a heart attack. He was put on Bivad BVS support and later transferred to Mt. Sinai and switched to the AB5000, which supported him for two months while he awaited transplant. |
 |
David Jones suffered from viral myocarditis but avoided a heart transplant through six days of Bi-VAD BVS 5000 support. He was flown to Presbyterian Hospital in Charlotte, NC where doctors discovered he was suffering from viral myocarditis. He was placed on Bi-VAD BVS 5000 support. After six days, his heart recovered and he was able to avoid having a transplant. He is back at work as an independent contractor and recently went to Capitol Hill to represent outstanding patient outcomes with medical technology. |
 |
Avimael Santos was 39 years old when he suffered cardiac arrest and shock following a procedure to repair a heart valve. Dr. Charles Moore at the University of Texas Health Science Center implanted the BVS 5000, a temporary heart assist device. The BVS did the pumping for his heart for two weeks, after which he was switched to a longer-term device and received a heart transplant at CHRISTUS Transplant Institute in San Antonio, Texas. Since his transplant, Avimael and his wife have welcomed a new baby into their family. |
add new comment Comments